Skip to main content
OpenTrials

Clinical trial condition

Urticaria

Explore clinical trials studying Urticaria. Study availability and eligibility vary by location and protocol.

320 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Urticaria trial results

Completed

A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines

NCT05048342

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Urayasu, Chiba, Japan
  • Novartis Investigative Site Izumiōtsu, Osaka, Japan
  • Novartis Investigative Site Neyagawa, Osaka, Japan
View all 13 locations
View Trial Details
Completed

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

NCT05032157

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Cahaba Derm and skin hlth ctr 27 Birmingham, Alabama, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Little Rock Allergy and Asthma Clnc Little Rock, Arkansas, United States
  • Allergy and Asthma Medical Group and Research Center San Diego, California, United States
View all 122 locations
View Trial Details
Completed

A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

NCT05368285

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Clinical Research Center of Alabama dba Allervie Clinical Research Birmingham, Alabama, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • Little Rock Allergy & Asthma CRC Little Rock, Arkansas, United States
  • Kern Research, Inc Bakersfield, California, United States
View all 56 locations
View Trial Details
Completed

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

NCT03858634

Conditions
Chronic Disease, Chronic Idiopathic Pruritus, Chronic Idiopathic Urticaria, +22 more
Locations
  • Site 106 Anniston, Alabama, United States
  • Site 110 Phoenix, Arizona, United States
  • Site 114 Hot Springs, Arkansas, United States
  • Site 103 Los Angeles, California, United States
View all 14 locations
View Trial Details
Completed

OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)

NCT05139810

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Ionis Investigative Site Scottsdale, Arizona, United States
  • Ionis Investigative Site San Diego, California, United States
  • Ionis Investigative Site Santa Monica, California, United States
  • Ionis Investigative Site Walnut Creek, California, United States
View all 51 locations
View Trial Details
Completed

A Safety and Efficacy Study of Ligelizumab in the Treatment of CSU in Japanese Patients Inadequately Controlled With H1- Antihistamines

NCT03907878

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Ichikawa, Chiba, Japan
  • Novartis Investigative Site Obihiro, Hokkaido, Japan
  • Novartis Investigative Site Kobe, Hyōgo, Japan
  • Novartis Investigative Site Nishinomiya, Hyōgo, Japan
View Trial Details

Related conditions